RxDoctor Payments Data

Elisa Illing, MD

Otolaryngology · Indianapolis, INNPI 1851619845

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.0%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Smith+Nephew at 55.1% of the total. 2025 is the largest year on record at $24,674, more than ten times the $199 reported in 2019. Among otolaryngology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$28,212in general payments, 2019–2025

Across 80 payments — averaging $352.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$16K
  • GSK$9K
  • Medtronic$777
  • Stryker$503
  • Acclarent, Inc$406
  • 3-d Matrix, Inc.$396
  • plus $2K from 11 others

What the payments were for

  • Consulting fees$4,05014%
  • Speaking & faculty fees$16,65659%
  • Travel & lodging$2,0807%
  • Food & beverage$5,42519%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$28,212 in reported general payments places this provider in the 95th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$93,886
Medicare patients
132
Services billed
472

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide88$2,168
Azelastine Hcl56$1,304
Fluticasone Propionate36$750
Famotidine36$467
Doxycycline Monohydrate14$305
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$136
Clindamycin Hcl11$99
Montelukast Sodium35$97
Mupirocin20$58
Prednisone21$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →